1 |
Kim, K. M., J. Y. Lee, C. K. Kim, and J. S. Kang. 2009. Isolation and characterization of surfactin produced by Bacillus polyfermenticus KJS-2. Arch. Pharm. Res. 32: 711-715.
|
2 |
Kim, P. I., H. Bai, D. Bai, H. Chae, S. Chung, Y. Kim, R. Park, and Y. -T. Chi. 2004. Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26. J. Applied. Microbiol. 97: 942-949.
|
3 |
Kim, P. I., Ryu, J., Kim, Y. H., Chi, Y. T., 2010. Production of biosurfactant lipopeptides iturin A, fengycin, and surfactin A from Bacillus subtillis CMB32 for control of Colletotrichum gloeosporioides. J. Microbiol. Biotechnol. 20:138-145
|
4 |
Lee, K. H., K. D. Jun, W. S. Kim, and H. D. Paik. 2001. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett. Appl. Microbiol. 32: 146-151.
|
5 |
Ma, E. L., Y. J. Choi, J. Choi, C. Pothoulakis, S. H. Rhee, and E. Im. 2010. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int. J. Cancer 127: 780-790.
|
6 |
Maget-Dana, R., L. Thimon, F. Peypoux, and M. Ptack. 1992. Surfactin/Iturin A interactions may explain the synergistic effect of surfactin on the biological properties of iturin A. Biochimie 74: 1047-1051.
|
7 |
McGrath, M. T. 2001. Fungicide resistance in cucurbit powdery mildew: Experiences and challenges. Plant Dis. 85: 236-245.
|
8 |
Nagorska, K., M. Bikowski, and M. Obuchowski. 2007. Multicellular behaviour and production of a wide variety of toxic substances support usage of Bacillus subtilis as a powerful biocontrol agent. Acta Biochim. Pol. 54: 495-508.
|
9 |
Nihorimbere, V., H. Cawoy, A. Seyer, A. Brunelle, P. Thonart, and M. Ongena. 2011. Impact of rhizosphere factors on cyclic lipopeptide signature from the plant beneficial strain Bacillus amyloliquefaciens S499. FEMS Microbiol. Ecol. 79: 176-191.
|
10 |
Ongena M, E. Jourdan, A. Adam, M. Paquot, A. Brans, B. Joris, J. L. Arpigny, P. Thonart. 2007. Surfactin and fengycin lipopeptides of Bacillus subtilis as elicitors of induced systemic resistance in plants. Environ. Microbiol. 9: 1084-1090.
|
11 |
Ongena, M. and P. Jacques. 2008. Bacillus lipopeptides: versatile weapons for plant disease biocontrol. Trends Microbiol. 16: 115-125.
|
12 |
Paulitz, T. C. and R. R. Bélanger. 2001. Biological control in greenhouse systems. Annu. Rev. Phytopathol. 39: 103-133.
|
13 |
Peypoux, F., J. M. Bonmatin, and J. Wallach. 1999. Recent trends in the biochemistry of surfactin. Appl. Microbiol. Biotechnol. 51: 553-563.
|
14 |
Pitt, J. I. and A. D. Hocking. 1999. Fungi and Food Spoilage. Aspen Publishers, Gaithersburg, MD, USA.
|
15 |
Ryoo, S. W., H. Y. Maeng, and P. J. Maeng. 1996. Purification and characterization of antifungal compounds produced by Bacillus subtilis KS1. Kor. J. Mycol. 24: 293-304.
|
16 |
Schallmey, M., A. Singh, and O. P. Ward. 2004. Development in the use of Bacillus species for industrial production. Can. J. Microbiol. 50: 1-17.
|
17 |
Sharma, R. R., D. Singh, and R. Singh. 2009. Biological control of postharvest diseases on fruits and vegetables by microbial antagonists: a review. Biol. Control 50: 205-221.
|
18 |
Stein, T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol. 56: 845-857.
|
19 |
Williams, B. H., Y. Hathout, and C. Fenselau. 2002. Structural characterization of lipopeptide biomarkers isolated from Bacillus globigii. J. Mass. Spectrom. 37: 259-264.
|
20 |
Yang, E. J. and H. C. Chang. 2007. Characterization of bacteriocin-like substances produced by Bacillus subtilis MJP1. Kor. J. Microbiol. Biotechnol. 35: 339-346.
|
21 |
Chen, H., Wang, L., Su, C. X., Gong, G. H., Wang, P., Yu, Z. L., 2008. Isolation and characterization of lipopeptide antibiotics produced by Bacillus subtillis. Lett. Appl. Microbiol. 47: 180-186.
|
22 |
Akpa, E., P. Jacques, B. wathelet, M. Paquot, R. Fuchs, H. Budzikiewiez, and P. Thonart. 2001. Influence of culture conditions on lipopeptide production by Bacillus subtilis. Appl. Biochem. Biotechnol. 91: 551-561.
|
23 |
Arguelles-Arias, A., M. Ongena, B. Halimi, Y. Lara, A. Brans, B. Joris, and P. Fickers. 2009. Bacillus amyloliquefaciens GA1 as a source of potent antibiotics and other secondary metabolites for biocontrol of plant pathogens. Microb. Cell Fact. 8: 63.
|
24 |
Athukorala, S. N. P., W. G. D. Fernando, and K. Y. Rashild. 2009. Identification of antifungal antibiotics of Bacillus species isolated from different microhabitats using polymerase chain reaction and MALDI-TOF mass spectrometry. Can. J. Microbiol. 55: 1021-1032.
|
25 |
Chitarra, G. S., P. Breeuwer, M. J. R. Nout, A. C. van Aelst, F. M. Rombouts, and T. Abee. 2003. An antifungal compound produced by Bacillus subtilis YM 10-20 inhibits germination of Penicillium roqueforti conidiospores. J. Appl. Microbiol. 94: 159-168.
|
26 |
FAO(Food and Agriculture Organisation). 2011. Global food Losses and Food Waste. http://www.fao.org/fileadmin/user_upload/ags/publications/GFL_web.pdf
|
27 |
Im, E., Y. J. Choi, C. H. Kim, C. Fiocchi, C. Pothoulakis, and S. H. Rhee. 2009. The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G999-G1008.
|
28 |
Grangemard, I., J. Wallach, and F. Peypoux. 1999. Evidence of surfactin hydrolysis by a bacterial endoprotease. Biotechnol. Lett. 21: 241-244.
|
29 |
Grover, M., L. Nain, S. B. singh, and A. K. Saxena. 2010. Molecular and biochemical approaches for characterization of antifungal trait of a potent biocontrol agent Bacillus subtilis RP24. Curr. Microbiol. 60: 99-106.
|
30 |
Hoover, D. G. and S. K. Harlander. 1993. Screening methods for detecting bacteriocin activity, pp. 23-29. In D. G. Hoover and L. R. Steenson (ed.), Bacteriocin of lactic acid bacteria. Academic Press, San Diego, CA.
|
31 |
Jung, J. H. and H. C. Chang. 2009. Antifungal activity of Bacillus polyfermenticus CJ6 isolated from meju. J. Korean Soc. Food Sci. Nutr. 38: 509-516.
|
32 |
Jung, J. H. and H. C. Chang. 2009. Bacillus polyfermenticus CJ9, isolated from meju, showing antifungal and antibacterial activities. Kor. J. Microbiol. Biotechnol. 37: 340-349.
|
33 |
Kim, D. H., H. K. Kim, K. M. Kim, C. K. Kim, M. H. Jeong, C. Y. Ko, K. H. Moon, and J. S. Kang. 2011. Antibacterial activities of macrolactin A and 7-O-succinyl mactolactin A from Bacillus polyfermenticus KJS-2 against vancomycinresistant Enterococci and methicillin-resistant Staphylococcus aureus. Arch. Pharm. Res. 34: 147-152.
|
34 |
Kim, H. S., H. Park, I. Y. Cho, H. D. Paik, and E. Park. 2006. Dietary supplementation of probiotic Bacillus polyfermenticus, Bispan strain, modulates natural killer cell and T cell subset populations and immunoglobulin G levels in human subjects. J. Med. Food 9: 321-327.
|
35 |
Kim, H. Y. and T. S. Lee. 2009. Toxicity and characteristics of antifungal substances produced by Bacillus amyloliquefaciens IUB158-03. J. Life Sci. 19: 1672-1678.
|